Skip to main content

Becton, Dickinson and Company

corporate_fare Company Profile

Becton, Dickinson and Company

BDX·NYSE·Industrial Applications And Services·CIK 0000010795

Becton, Dickinson and Company (BD) is a global medical technology company that develops, manufactures, and sells a wide range of medical supplies, devices, laboratory equipment, and diagnostic products. These products are used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. BD's solutions aim to improve medication management and patient safety, support infection prevention, equip surgical and interventional procedures, improve drug delivery, aid anesthesiology care, enhance the diagnosis of infectious diseases and cancers, and advance cellular research and applications. As of September 30, 2025, BD operated through three worldwide business segments: BD Medical, BD Life Sciences, and BD Interventional. Effective October 1, 2025, BD reorganized into five distinct, separately-managed segments: Medical Essentials, Connected Care, BioPharma Systems, Interventional, and Life Sciences. The Life Sciences segment will remain a critical part of BD until the separation and combination of its Biosciences and Diagnostic Solutions business with Waters Corporation is completed. BD Medical produces a broad array of medical technologies and devices used to improve healthcare delivery in various settings. BD was incorporated in New Jersey in November 1906, succeeding a New York business started in 1897.

Becton, Dickinson and Company (NYSE:BDX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 33 items for BDX at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Becton Dickinson Raises Annual Profit Forecast, Beats Q2 Estimates on Strong Device Sales
  • Becton Dickinson Appoints Vitor Roque as Permanent CFO, Details Compensation Package
  • BD Reports Strong Q2 Results, Raises EPS Guidance, Completes $2B Share Buyback & $2.1B Debt Repayment
  • Becton Dickinson Shares Plunge 26% on Q4 Revenue Miss, Guidance Cut
  • EVP and Interventional Segment President Richard Byrd Announces Retirement

Financial Snapshot

Fiscal year ended September 30, 2025
Revenue
$21.84B
Net Income
$1.68B
Diluted EPS
$5.82
Gross Profit
$9.93B
Operating Income
$2.58B
Cash & Equivalents
$641M
Total Debt
$19.18B
Debt / Equity
0.76×
Net Margin
7.7%
Shares Outstanding
287.65M sh
Source: 10-K · filed 2025-11-25 · accession 0000010795-25-000099
$212.78
52-week range · as of 2026-11-05 $127.54 – $212.78
Market cap
$57.96B
Volume
2M (1.0× avg)
3-mo avg 1.9M
Live data · 2026-11-22 12:45 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BDX - Filings & News (Page 2)

BDX
May 07, 2026, 7:56 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $147.98
Real-time Price: $212.78 info
Change: +$64.80 (+44%) info
Market Cap: $57.958B info
BDX
May 07, 2026, 6:33 AM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $149.50
Real-time Price: $212.78 info
Change: +$63.28 (+42%) info
Market Cap: $57.958B info
BDX
May 07, 2026, 6:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $149.50
Real-time Price: $212.78 info
Change: +$63.28 (+42%) info
Market Cap: $57.958B info
BDX
Apr 10, 2026, 4:05 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $154.22
Real-time Price: $212.78 info
Change: +$58.56 (+38%) info
Market Cap: $57.958B info
BDX
Apr 09, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $155.46
Real-time Price: $212.78 info
Change: +$57.32 (+37%) info
Market Cap: $57.958B info
BDX
Apr 02, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $154.51
Real-time Price: $212.78 info
Change: +$58.27 (+38%) info
Market Cap: $57.958B info
BDX
Feb 25, 2026, 4:25 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $180.96
Real-time Price: $212.78 info
Change: +$31.82 (+18%) info
Market Cap: $57.958B info
BDX
Feb 10, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $171.68
Real-time Price: $212.78 info
Change: +$41.10 (+24%) info
Market Cap: $57.958B info
BDX
Feb 09, 2026, 4:19 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $207.40
Real-time Price: $212.78 info
Change: +$5.38 (+3%) info
Market Cap: $57.958B info
BDX
Feb 09, 2026, 4:18 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $207.40
Real-time Price: $212.78 info
Change: +$5.38 (+3%) info
Market Cap: $57.958B info
BDX
Feb 09, 2026, 6:31 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $209.02
Real-time Price: $212.78 info
Change: +$3.76 (+2%) info
Market Cap: $57.958B info
BDX
Feb 05, 2026, 4:21 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $204.08
Real-time Price: $212.78 info
Change: +$8.70 (+4%) info
Market Cap: $57.958B info
BDX
Feb 05, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $204.08
Real-time Price: $212.78 info
Change: +$8.70 (+4%) info
Market Cap: $57.958B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets